Myeloablative hematopoietic stem cell transplantation for myelodysplastic syndrome in patients younger than 55 years: impact of comorbidity and disease burden on the long-term outcome.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples